Massive statement to call a $3.5m AUD NIHR fully funded trial with some of the most credible respiratory groups in the world "fluff"
Not only does this setup the pathway to open up the UK market with NHS support, but it compliments the traction in the US.
From the announcement "Interim data available for analysis as the trial progresses" ie just because the trial is funded for 30 months, doesn't mean you need to wait until the end for beneficial outcomes - 1464 children is not an in-significant number.
Like you, I am also eager to see more US progress, but I don't see this trial distracting from the companies focus on US commercialisation in any way.
Massive statement to call a $3.5m AUD NIHR fully funded trial...
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
0.004(13.3%) |
Mkt cap ! $36.03M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.4¢ | 3.0¢ | $36.75K | 1.184M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 224180 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 79999 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.4¢ |
Change
0.004 ( 13.3 %) |
||||
| Open | High | Low | Volume | ||
| 3.2¢ | 3.4¢ | 3.2¢ | 71127 | ||
| Last updated 14.52pm 03/05/2024 ? | |||||
| RSH (ASX) Chart |